Alerts will be sent to your verified email
Verify Email
PGHL
|
Procter&Gamble Healt
|
Marksans Pharma
|
Sanofi India
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceutical Sector
|
|||
|
Domestic Sales Growth - YoY
|
20.1 % | n/a | 1.7 % |
|
Financials
|
|||
|
5 yr Average ROE
|
30.46 % | 17.57 % | 52.02 % |
|
5yr average Equity Multiplier
|
2.99 | 1.33 | 4.62 |
|
5yr Average Asset Turnover Ratio
|
0.57 | 0.9 | 0.47 |
|
5yr Avg Net Profit Margin
|
17.93 % | 14.56 % | 24.38 % |
|
Price to Book
|
19.17 | 4.13 | 14.86 |
|
P/E
|
34.24 | 26.74 | 30.94 |
|
5yr Avg Cash Conversion Cycle
|
-158.56 Days | 71.65 Days | 4.83 Days |
|
Inventory Days
|
36.98 Days | 89.77 Days | 66.8 Days |
|
Days Receivable
|
29.14 Days | 65.99 Days | 31.98 Days |
|
Days Payable
|
177.2 Days | 88.81 Days | 63.37 Days |
|
5yr Average Interest Coverage Ratio
|
337.3 | 38.03 | 906.11 |
|
5yr Avg ROCE
|
19.93 % | 21.95 % | 27.19 % |
|
5yr Avg Operating Profit Margin
|
24.91 % | 20.32 % | 24.71 % |
|
5 yr average Debt to Equity
|
0.0 | 0.02 | 0.0 |
|
5yr CAGR Net Profit
|
-4.58 % | 10.03 % | 31.63 % |
|
5yr Average Return on Assets
|
10.24 % | 13.19 % | 11.5 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
51.82 % | 43.87 % | 60.4 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -4.38 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
4.04 % | 2.6 % | 1.2 % |
|
Procter&Gamble Healt
|
Marksans Pharma
|
Sanofi India
|
|
|---|---|---|---|
|
Segment Break-Up
|
Segment Break-Up
|
-
|
-
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Drug Delivery Break-Up
|
Drug Delivery Break-Up
|
-
|
-
|
|
Therapeutic Area Break-Up
|
Therapeutic Area Break-Up
|
-
|
-
|
|
Asset Break-Up
|
Asset Break-Up
|
-
|
-
|